
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
Quyuan Tao, Jiaxin Du, Xiantao Li, et al.
Drug Development and Industrial Pharmacy (2020) Vol. 46, Iss. 8, pp. 1345-1353
Open Access | Times Cited: 192
Quyuan Tao, Jiaxin Du, Xiantao Li, et al.
Drug Development and Industrial Pharmacy (2020) Vol. 46, Iss. 8, pp. 1345-1353
Open Access | Times Cited: 192
Showing 1-25 of 192 citing articles:
Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms
Kai Huang, Pan Zhang, H. H. Zhang, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107843-107843
Open Access | Times Cited: 382
Kai Huang, Pan Zhang, H. H. Zhang, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107843-107843
Open Access | Times Cited: 382
Network Pharmacology Approach for Medicinal Plants: Review and Assessment
Fatima Noor, Muhammad Tahir ul Qamar, Usman Ali Ashfaq, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 572-572
Open Access | Times Cited: 230
Fatima Noor, Muhammad Tahir ul Qamar, Usman Ali Ashfaq, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 572-572
Open Access | Times Cited: 230
Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 175
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 175
Network pharmacology: a bright guiding light on the way to explore the personalized precise medication of traditional Chinese medicine
Ling Li, Lele Yang, Liuqing Yang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 47
Ling Li, Lele Yang, Liuqing Yang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 47
Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer
Ji Zhou, Haoying Li, Ben Wu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Ji Zhou, Haoying Li, Ben Wu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review
Megh Pravin Vithalkar, K. Sandra, Bharath Harohalli Byregowda, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113979-113979
Open Access | Times Cited: 1
Megh Pravin Vithalkar, K. Sandra, Bharath Harohalli Byregowda, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113979-113979
Open Access | Times Cited: 1
Research progress of traditional Chinese medicine against COVID-19
Wei Ren, Pan Liang, Yue Ma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111310-111310
Open Access | Times Cited: 69
Wei Ren, Pan Liang, Yue Ma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111310-111310
Open Access | Times Cited: 69
Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study
Yue-Yu Gu, Min Zhang, Huan Cen, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245209-e0245209
Open Access | Times Cited: 68
Yue-Yu Gu, Min Zhang, Huan Cen, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245209-e0245209
Open Access | Times Cited: 68
Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial
Jia Liu, Wei Yang, Yue Liu, et al.
Phytomedicine (2021) Vol. 91, pp. 153671-153671
Open Access | Times Cited: 58
Jia Liu, Wei Yang, Yue Liu, et al.
Phytomedicine (2021) Vol. 91, pp. 153671-153671
Open Access | Times Cited: 58
Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review
Xiaomin Kang, De Jin, Linlin Jiang, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 54
Xiaomin Kang, De Jin, Linlin Jiang, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 54
Paeoniflorin attenuates polystyrene nanoparticle-induced reduction in reproductive capacity and increase in germline apoptosis through suppressing DNA damage checkpoints in Caenorhabditis elegans
Xin Hua, Xiao Feng, Yingshun Hua, et al.
The Science of The Total Environment (2023) Vol. 871, pp. 162189-162189
Closed Access | Times Cited: 33
Xin Hua, Xiao Feng, Yingshun Hua, et al.
The Science of The Total Environment (2023) Vol. 871, pp. 162189-162189
Closed Access | Times Cited: 33
Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
Ling Ye, Shicheng Fan, Pengfei Zhao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3598-3637
Open Access | Times Cited: 26
Ling Ye, Shicheng Fan, Pengfei Zhao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3598-3637
Open Access | Times Cited: 26
Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing
Md. Parvez Mosharaf, Md. Selim Reza, Md. Kaderi Kibria, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35
Md. Parvez Mosharaf, Md. Selim Reza, Md. Kaderi Kibria, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35
Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy
Shaojie Fu, Yena Zhou, Cong Hu, et al.
BMC Complementary Medicine and Therapies (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Shaojie Fu, Yena Zhou, Cong Hu, et al.
BMC Complementary Medicine and Therapies (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches
Fee Faysal Ahmed, Md. Selim Reza, Md. Shahin Sarker, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266124-e0266124
Open Access | Times Cited: 29
Fee Faysal Ahmed, Md. Selim Reza, Md. Shahin Sarker, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266124-e0266124
Open Access | Times Cited: 29
Triterpenoid saponins from Ilex pubescens promote blood circulation in blood stasis syndrome by regulating sphingolipid metabolism and the PI3K/AKT/eNOS signaling pathway
Jie Chen, Di Cao, Shiqin Jiang, et al.
Phytomedicine (2022) Vol. 104, pp. 154242-154242
Closed Access | Times Cited: 27
Jie Chen, Di Cao, Shiqin Jiang, et al.
Phytomedicine (2022) Vol. 104, pp. 154242-154242
Closed Access | Times Cited: 27
Kaempferol has potential anti‐coronavirus disease 2019 (COVID ‐19) targets based on bioinformatics analyses and pharmacological effects on endotoxin‐induced cytokine storm
Yaoxiang Sun, Qing Tao, Yang Cao, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 6, pp. 2290-2304
Closed Access | Times Cited: 17
Yaoxiang Sun, Qing Tao, Yang Cao, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 6, pp. 2290-2304
Closed Access | Times Cited: 17
Biologic Mechanisms of Macrophage Phenotypes Responding to Infection and the Novel Therapies to Moderate Inflammation
Renhao Ni, Lingjing Jiang, Chaohai Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8358-8358
Open Access | Times Cited: 17
Renhao Ni, Lingjing Jiang, Chaohai Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8358-8358
Open Access | Times Cited: 17
Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19
Bo Zhang, Fanghua Qi
BioScience Trends (2023) Vol. 17, Iss. 1, pp. 14-20
Open Access | Times Cited: 15
Bo Zhang, Fanghua Qi
BioScience Trends (2023) Vol. 17, Iss. 1, pp. 14-20
Open Access | Times Cited: 15
MzDOCK: A free ready‐to‐use GUI ‐based pipeline for molecular docking simulations
Muzammil Kabier, Nicola Gambacorta, Daniela Trisciuzzi, et al.
Journal of Computational Chemistry (2024) Vol. 45, Iss. 23, pp. 1980-1986
Closed Access | Times Cited: 6
Muzammil Kabier, Nicola Gambacorta, Daniela Trisciuzzi, et al.
Journal of Computational Chemistry (2024) Vol. 45, Iss. 23, pp. 1980-1986
Closed Access | Times Cited: 6
Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic
Wan‐Yi Ho, Zi-han Shen, Yijing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30080-e30080
Open Access | Times Cited: 5
Wan‐Yi Ho, Zi-han Shen, Yijing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30080-e30080
Open Access | Times Cited: 5
The Potential Roles of Host Cell miRNAs in Fine-Tuning Bovine Coronavirus (BCoV) Molecular Pathogenesis, Tissue Tropism, and Immune Regulation
Abid Ullah Shah, Maged Gomaa Hemida
Microorganisms (2024) Vol. 12, Iss. 5, pp. 897-897
Open Access | Times Cited: 5
Abid Ullah Shah, Maged Gomaa Hemida
Microorganisms (2024) Vol. 12, Iss. 5, pp. 897-897
Open Access | Times Cited: 5
Exploring the Potential Mechanism of Action of Wutou-Guizhi Decoction in the Treatment of Rheumatoid Arthritis through Network Pharmacology Analysis
Changhong Li, Shiyi Tang, Chunjin Hang, et al.
Computational Biology and Chemistry (2025) Vol. 115, pp. 108314-108314
Closed Access
Changhong Li, Shiyi Tang, Chunjin Hang, et al.
Computational Biology and Chemistry (2025) Vol. 115, pp. 108314-108314
Closed Access
Network pharmacology predicts targets and pathways of herbal components for the treatment of pneumonia: A review
Dongxin Yang, Cuilian Chen, Qian Zhang, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41372-e41372
Open Access
Dongxin Yang, Cuilian Chen, Qian Zhang, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41372-e41372
Open Access
Drug likeliness, pharmacokinetics profiling and efficacy of Polyscias fulva bioactive compounds in the management of uterine fibroids; An Integrative in silico and in vivo approach
Kenedy Kiyimba, Lincoln Munyendo, Samuel Baker Obakiro, et al.
Journal of Molecular Graphics and Modelling (2025) Vol. 137, pp. 108984-108984
Closed Access
Kenedy Kiyimba, Lincoln Munyendo, Samuel Baker Obakiro, et al.
Journal of Molecular Graphics and Modelling (2025) Vol. 137, pp. 108984-108984
Closed Access